We focus on ten societal areas.
TNO cooperates with companies, the public sector and other organisations, to apply our knowledge and expertise with and for others.
We develop knowledge not for its own sake, but for practical application.
TNO offers you the chance to do groundbreaking work and help customers and society with innovative, practical and smart solutions.
On TNO Insights you can read in-depth interviews and articles. Get inspired by TNO’s innovations!
Look through the eyes of TNO and discover how we contribute to a brighter future by developing pharmaceutical innovations.
Pills are an incredible invention, but they take too little account of the differences between people. Fortunately, new methods are enabling us to test medicines much more quickly, safely and accurately. New production methods are also making it possible to better attune medicines to different body types. The first personalised 3D pills are already being printed in TNO’s laboratories.
A child needs a much lower medicinal dose than an adult, for example. How can you ensure that a pill has exactly the right dosage? One solution is 3D printing technology. TNO is working with Erasmus Medical Center on innovations that will enable the production of tailormade drugs for each patient.
It takes about 13 years to develop a new drug and costs between 1.3 and 2.5 billion dollars. This is because safety testing can often take place only in the final (expensive) phase of a clinical trial. TNO has developed an innovative technology that allows safety testing to take place earlier, combining microtracing with Accelerator Mass Spectrometry (AMS). In this way, we prevent medicines with a high safety risk from proceeding to expensive, large-scale clinical trials. The faster and safer development of medicines benefits everyone, especially patients.
Treating a disease not with medicines but through a personalised lifestyle. Can you envision it? TNO’s Suzan Wopereis and her colleagues can. They have investigated why a specific treatment for type 2 diabetes works for one patient but not for another. Their discoveries have resulted in a personalised approach to lifestyle changes through which one’s lifestyle can be used as a form of treatment. The aim of this research is to prove that exercise tailored to the individual can lead to a remission of type 2 diabetes for a large proportion of patients.